Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More
Texas Medical Center
1102 Bates Ave.Suite 1770
Houston, TX 77030
Robin Parihar, MD, PhD
Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Research Member, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
Faculty Member, Center for Cell and Gene Therapy, Baylor College of Medicine
|Baylor College of Medicine||Fellowship||Pediatric Hematology Oncology||2015|
|Cleveland Clinic Foundation||Residency||Pediatrics||2012|
|Wright State University||Medical School||Doctor of Medicine||2008|
|Ohio State University||Doctorate of Philosophy, Immunology|
|Wake Forest University||University||Chemistry|
Dr. Robin Parihar is a pediatric hematologist-oncologist with a clinical interest in children with solid tumors such as rhabdomyosarcoma and neuroblastoma. He serves as a member of the Solid Tumor Programs, including the Neuroblastoma Program, and specializes in patients with tumors of the bone, muscle, and soft tissue. He is board certified by the American Board of Pediatrics in general pediatrics and pediatric hematology/oncology.
|American Academy of Pediatrics (AAP)||Member|
|American Association for Cancer Research (AACR)||Member|
|American Society of Clinical Oncology (ASCO)||Member|
|American Society of Pediatric Hematology and Oncology (ASPHO)||Member|
|Children’s Oncology Group (COG)||Member|
Dr. Parihar’s research interests center around finding new ways in which to enhance the body’s own immune system to detect and destroy cancer. He has worked in the field of immunology for over a decade and has contributed to numerous translational research projects investigating the role of various immune cells in the control of cancer.
Dr. Parihar's lab, located within the Center for Cell and Gene Therapy, investigates the role of a specific type of immune cell called the natural killer (NK) cell. His research projects aim to enhance NK cell functions in order to target the tumor microenvironment, essentially getting rid of the accessory cells that help a tumor resist standard therapies. He is introducing the enhanced NK cells as therapy for children with advanced cancers. In addition, his lab has established lab models to better understand how the tumor microenvironment suppresses the immune system, in order to develop new approaches to overcome this inhibition and improve immune-based therapies for pediatric cancers.
Dr. Parihar has served as a principle investigator and collaborator on grants examining NK cells as anti-cancer therapy and published extensively on the subject. Besides his interest in immunology and its relation to cancer, Dr. Parihar also places great importance in the role of the physician at the bedside, as an advocate and communicator for patients and their families. Thus, he has always been interested in clinically‑relevant research, with the ultimate goal of translating basic science discoveries made in his lab into novel clinical treatments for children with cancer.
Awards & Honors
Aventis Oncology Scholar-in-Training Award
American Association for Cancer Research (AACR) (2002)
Dissertation Research Award
Susan G Komen Breast Cancer Foundation (2003)
Takeda Pharmaceuticals Scholar-in-Training Award
American Association for Cancer Research (AACR) (2004)
Trainee Research Award
American Society of Hematology (ASH) (2011)
Research Poster Award, First Place
Texas Children's Cancer Center Research Symposium, Baylor College of Medicine (2015)
Faculty Teaching Award
Center for Cell and Gene Therapy, Baylor College of Medicine (2015)
Distinguished Young Investigator Research Award
Immuno-Oncology Young Investigators’ Forum (2018)
Young Investigator Award
American Society of Pediatric Hematology/Oncology (ASPHO) (2018)
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.